F.D.A. Rejects Closely Watched Lung Cancer Drug From China

New York Times - Nov 15, 2026

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.

Read full article

More News

The Financial Metrics

The Financial Metrics delivers breaking news and delves into the insights of business with progressive financial advice for today’s advanced business environment.

NEWSLETTER